X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Indoco Remedies with Mic Electronics - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

INDOCO REMEDIES vs MIC ELECTRONICS - Comparison Results

INDOCO REMEDIES    Change

Indoco Remedies is engaged in the manufacturing and marketing of formulations and active pharmaceutical ingredients (APIs) for domestic as well as the international markets. The company's focus areas include anti-infective, respiratory, anti-diabetic... More

MIC ELECTRONICS 
   Change

Incorporated in 1986, MIC Electronics is a Hyderabad based company whose business revolves mainly around LED (light emitting diode) and LED based products. The company broadly has two segments media, and informatics and communications (ICT). The form... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    INDOCO REMEDIES MIC ELECTRONICS INDOCO REMEDIES/
MIC ELECTRONICS
 
P/E (TTM) x 22.6 33.0 68.4% View Chart
P/BV x 2.7 0.3 778.2% View Chart
Dividend Yield % 0.8 0.0 -  

Financials

 INDOCO REMEDIES   MIC ELECTRONICS
EQUITY SHARE DATA
    INDOCO REMEDIES
Mar-17
MIC ELECTRONICS
Mar-16
INDOCO REMEDIES/
MIC ELECTRONICS
5-Yr Chart
Click to enlarge
High Rs36030 1,221.7%   
Low Rs2498 3,277.6%   
Sales per share (Unadj.) Rs119.08.3 1,438.8%  
Earnings per share (Unadj.) Rs8.4-6.7 -125.3%  
Cash flow per share (Unadj.) Rs15.2-6.2 -244.8%  
Dividends per share (Unadj.) Rs1.600-  
Dividend yield (eoy) %0.50-  
Book value per share (Unadj.) Rs70.713.9 509.1%  
Shares outstanding (eoy) m92.15166.14 55.5%   
Bonus/Rights/Conversions -IS-  
Price / Sales ratio x2.62.2 114.2%   
Avg P/E ratio x36.4-2.8 -1,311.0%  
P/CF ratio (eoy) x20.0-3.0 -671.1%  
Price / Book Value ratio x4.31.3 322.7%  
Dividend payout %19.10-   
Avg Mkt Cap Rs m28,0833,082 911.2%   
No. of employees `0006.0NA-   
Total wages/salary Rs m2,16735 6,262.1%   
Avg. sales/employee Rs Th1,817.0NM-  
Avg. wages/employee Rs Th359.0NM-  
Avg. net profit/employee Rs Th127.7NM-  
INCOME DATA
Net Sales Rs m10,9681,374 798.0%  
Other income Rs m4034 115.4%   
Total revenues Rs m11,0071,409 781.4%   
Gross profit Rs m1,565439 356.6%  
Depreciation Rs m63375 842.6%   
Interest Rs m625 1,321.3%   
Profit before tax Rs m909393 231.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-1,962 0.0%   
Tax Rs m139-460 -30.2%   
Profit after tax Rs m771-1,109 -69.5%  
Gross profit margin %14.331.9 44.7%  
Effective tax rate %15.3-116.9 -13.0%   
Net profit margin %7.0-80.7 -8.7%  
BALANCE SHEET DATA
Current assets Rs m5,7252,483 230.6%   
Current liabilities Rs m5,4542,368 230.3%   
Net working cap to sales %2.58.3 29.6%  
Current ratio x1.01.0 100.1%  
Inventory Days Days62200 31.1%  
Debtors Days Days72251 28.6%  
Net fixed assets Rs m5,3071,375 386.0%   
Share capital Rs m184332 55.5%   
"Free" reserves Rs m6,3311,364 464.1%   
Net worth Rs m6,5162,307 282.4%   
Long term debt Rs m1,323128 1,030.5%   
Total assets Rs m11,9704,855 246.5%  
Interest coverage x15.684.7 18.5%   
Debt to equity ratio x0.20.1 364.9%  
Sales to assets ratio x0.90.3 323.7%   
Return on assets %7.0-22.7 -30.6%  
Return on equity %11.8-48.1 -24.6%  
Return on capital %12.4-64.2 -19.3%  
Exports to sales %03.3 0.0%   
Imports to sales %012.0 0.0%   
Exports (fob) Rs mNA45 0.0%   
Imports (cif) Rs mNA165 0.0%   
Fx inflow Rs m4,50745 10,015.3%   
Fx outflow Rs m1,141166 685.7%   
Net fx Rs m3,366-121 -2,771.1%   
CASH FLOW
From Operations Rs m886-220 -402.2%  
From Investments Rs m-1,706-7 23,363.0%  
From Financial Activity Rs m1,316231 570.3%  
Net Cashflow Rs m4973 17,124.1%  

Share Holding

Indian Promoters % 59.2 8.0 740.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 12.5 0.0 -  
FIIs % 6.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 22.4 91.2 24.6%  
Shareholders   12,805 43,926 29.2%  
Pledged promoter(s) holding % 0.0 54.4 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare INDOCO REMEDIES With:   INGERSOLL RAND  CHOLAMANDALAM INVEST.  EDELWEISS FINANCIAL  NALWA SONS INV  CREST VENTURES  



Today's Market

Sensex Finishes on a Strong Note; Bank & Realty Stocks Rally(Closing)

Indian share markets surged further in the afternoon session and finished in the green for the second straight session on heavy buying in realty stocks, metal stocks and bank stocks.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

Aug 16, 2017

The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

INDOCO REMEDIES SHARE PRICE


Aug 23, 2017 (Close)

TRACK INDOCO REMEDIES

  • Track your investment in INDOCO REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON INDOCO REMEDIES

INDOCO REMEDIES - TALWALKARS BETTER VAL. COMPARISON

COMPARE INDOCO REMEDIES WITH

MARKET STATS